Con Panousis Selected Research

Factor XIIa (Coagulation Factor XIIa)

1/2022	Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.
1/2016	The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
1/2016	FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Con Panousis Research Topics

Disease

3	Thrombosis (Thrombus) 11/2021 - 02/2014
3	Inflammation (Inflammations) 01/2020 - 01/2016
2	Idiopathic Pulmonary Fibrosis 01/2022 - 05/2014
2	Neoplasms (Cancer) 01/2020 - 08/2003
2	Arthritis (Polyarthritis) 01/2018 - 12/2016
2	Hemorrhage 01/2016 - 02/2014
2	Asthma (Bronchial Asthma) 01/2016 - 05/2014
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Abdominal Aortic Aneurysm 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Atherosclerosis 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Hemophilia A (Haemophilia) 11/2021
1	Glomerulonephritis 01/2021
1	Rupture 01/2020
1	Aneurysm (Aneurysms) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Lung Injury 01/2017
1	Human Influenza (Influenza) 12/2016
1	Rheumatoid Arthritis 12/2016
1	Joint Diseases (Joint Disease) 12/2016
1	Infections 12/2016
1	Neuroinflammatory Diseases 01/2016
1	Brain Ischemia (Cerebral Ischemia) 01/2016
1	Stroke (Strokes) 01/2016
1	Reperfusion Injury 01/2016
1	Edema (Dropsy) 08/2015
1	Hereditary Angioedema Type III 08/2015
1	Wounds and Injuries (Trauma) 02/2014
1	Carcinoma (Carcinomatosis) 08/2003

Drug/Important Bio-Agent (IBA)

6	Factor XII (Hageman Factor)IBA 01/2022 - 02/2014
3	Factor XIIa (Coagulation Factor XIIa)IBA 01/2022 - 01/2016
3	CytokinesIBA 01/2018 - 05/2014
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2018
2	Peptide Hydrolases (Proteases)FDA Link 08/2015 - 02/2014
2	Neutralizing AntibodiesIBA 08/2015 - 02/2014
1	Angiotensin IIIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	von Willebrand FactorIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	AlbuminsIBA 11/2021
1	Factor VIII (Coagulation Factor VIII)IBA 11/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	KininsIBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	ADAM17 ProteinIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Kallikreins (Kallikrein)IBA 01/2020
1	Fc Receptors (Fc Receptor)IBA 01/2018
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	Histones (Histone)IBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2017
1	CollagenIBA 12/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2016
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 12/2016
1	SteroidsIBA 01/2016
1	BradykininIBA 08/2015
1	Interleukin-13IBA 05/2014
1	Heparin (Liquaemin)FDA LinkGeneric 02/2014
1	Hemostatics (Antihemorrhagics)IBA 02/2014
1	FibrinIBA 02/2014
1	AnticoagulantsIBA 02/2014
1	A-factor (Streptomyces)IBA 02/2014
1	ErbB Receptors (EGF Receptor)IBA 08/2003
1	epidermal growth factor receptor VIIIIBA 08/2003
1	AntigensIBA 08/2003
1	Hu3S193 monoclonal antibodyIBA 08/2003
1	monoclonal antibody 806IBA 08/2003

Therapy/Procedure

3	Therapeutics 12/2016 - 08/2003
1	Extracorporeal Membrane Oxygenation 01/2016
1	Extracorporeal Circulation 02/2014